TD Cowen Maintains Buy on PROCEPT BioRobotics, Raises Price Target to $99
Portfolio Pulse from Benzinga Newsdesk
TD Cowen analyst Joshua Jennings maintains a Buy rating on PROCEPT BioRobotics and raises the price target from $75 to $99.
September 16, 2024 | 2:46 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
TD Cowen analyst Joshua Jennings has increased the price target for PROCEPT BioRobotics from $75 to $99 while maintaining a Buy rating. This suggests a positive outlook for the company's stock.
The increase in price target from $75 to $99 by TD Cowen, along with the maintained Buy rating, indicates a strong positive sentiment from the analyst. This is likely to boost investor confidence and could lead to a short-term increase in the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100